Assessing lung health using ultrasound in emphysema patients
Official title: Assessment of Pulmonary EmphySema: the Clinical -ULtrasonographic APproach to chronIc Obstructive Pulmonary Disease
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06533371 · Data updated 2026-11-12
This study is testing if lung ultrasound can help doctors better understand lung health in people with emphysema compared to healthy individuals and those with lung cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1628 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Drugs / interventions | radiation |
| Locations | 4 sites (Acquaviva delle Fonti and 3 other locations) |
| Status | Recruiting |
| Started | September 4, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06533371 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include outpatients and inpatients with chronic obstructive pulmonary disease or lung cancer who have CT evidence of panlobular or paraseptal emphysema.
✕Probably not a fit
Patients who are pregnant, pediatric, or unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to explore the correlations between lung ultrasonographic (LUS) patterns and high-resolution computed tomography (HRCT) findings in patients with panlobular or paraseptal emphysema. It will involve comparing LUS data from COPD patients, lung cancer screening participants, and those with suspected lung cancer against healthy volunteers. The study seeks to enhance understanding of how ultrasound can indicate underlying lung conditions, particularly when the lungs are still aerated. By analyzing these correlations, researchers hope to improve diagnostic accuracy and patient management.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic techniques for emphysema and related lung conditions, enhancing patient care.
How similar studies have gone: While the use of lung ultrasound in assessing thoracic diseases is established, this specific application in emphysema is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * outpatients in follow-up for chronic obstructive pulmonary disease, in stable conditions, with computed tomographic evidence of panlobular or paraseptal emphysema. * Inpatients, admitted to the hospital due to acute exacerbation of chronic obstructive pulmonary disease, with computed tomographic evidence of panlobular or paraseptal emphysema. * Subjects who participate in the screening program for lung cancer with computed tomographic evidence of panlobular or paraseptal emphysema. * Outpatients / Inpatients with suspected/known lung cancer and computed tomographic evidence of panlobular or paraseptal emphysema. * Patients able to give written informed consent. Exclusion Criteria: * pregnancy. * Pediatric population. * Patients unable to express written informed consent.
Where it's running
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy Recruiting -
Ente Ecclesiastico, Ospedale Generale Regionale "F. Miulli"
Acquaviva delle Fonti, Italy Not yet recruiting -
A.O.R.N. "A. Cardarelli"
Naples, Italy Not yet recruiting -
University of Trento
Trento, Italy Not yet recruiting
Study contacts
- Principal investigator: Riccardo Inchingolo, MD, PhD — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Riccardo Inchingolo, MD, PhD
- Email: riccardo.inchingolo@policlinicogemelli.it
- Phone: 011390630156062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Xenon MRI test for lung changes after Apreo BREATHE airway treatment in emphysema
This study tests whether hyperpolarized Xenon MRI can show regional ventilation and gas-exchange changes after the Apreo BREATHE airway scaffolds in people with emphysema and air trapping.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
-
Testing CE1226 doses to slow lung disease in adults with alpha-1 antitrypsin deficiency
This trial tests two active doses of CE1226 to see if they slow lung density decline in adults with AAT deficiency and emphysema over 3 years compared with the standard 60 mg/kg dose.
-
Implant to help adults with severe emphysema
This study will test whether an implantable artificial bronchus can improve breathing and safety in adults with severe COPD/emphysema.
-
Endobronchial silicone valve to help breathing in people with severe emphysema
This trial tests whether placing a silicone valve in the airways of one lung region can improve breathing for people with severe emphysema when added to usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.